BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2021 12:21:18 PM | Browse: 282 | Download: 309
 |
Received |
|
2021-05-29 01:37 |
|
Peer-Review Started |
|
2021-05-29 01:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-22 18:29 |
|
Revised |
|
2021-07-12 16:35 |
|
Second Decision |
|
2021-12-24 04:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-25 19:54 |
|
Articles in Press |
|
2021-12-25 19:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-29 14:56 |
|
Publish the Manuscript Online |
|
2021-12-31 12:21 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Risk of hepatocellular carcinoma after hepatitis C virus cure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria Alejandra Luna-Cuadros, Hao-Wei Chen, Hira Hanif, Mukarram Jamat Ali, Muzammil Muhammad Khan and Daryl Tan-Yeung Lau |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Daryl Tan-Yeung Lau, MD, MSc, Associate Professor, Liver Center, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 4A, Boston, MA 02215, United States. dlau@bidmc.harvard.edu |
| Key Words |
Hepatitis C virus cure; Hepatocellular carcinoma; Hepatocellular carcinoma risk models; Fibrosis markers; Transient elastography |
| Core Tip |
Direct-acting antivirals (DAA) therapy has revolutionized the treatment for chronic hepatitis C. However, the development of hepatocellular carcinoma (HCC) after achieving DAA-induced sustained virologic response remains a significant concern, especially those with advanced fibrosis. It is critically important to monitor hepatic fibrosis and continue HCC surveillance for patients with pre-existing cirrhosis. Lack of hepatic regression and several comorbid conditions are associated with HCC risks. Some promising models for predicting HCC risks after hepatitis C virus cure are in development. |
| Publish Date |
2021-12-31 12:21 |
| Citation |
Luna-Cuadros MA, Chen HW, Hanif H, Ali MJ, Khan MM, Lau DTY. Risk of hepatocellular carcinoma after hepatitis C virus cure. World J Gastroenterol 2022; 28(1): 96-107 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i1/96.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i1.96 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
